Effectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and Adolescents

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-14
SponsorUniversity of Aarhus

About this trial

The main purpose is to investigate the effectiveness of a 10-week multicomponent camp intervention to reduce BE behavior in children and adolescents and explore in a randomized controlled setting if a parent-based BED-intervention has any add-on effect, attenuating the development of BE behavior in this sample. The study will include an initial follow-up assessment scheduled 10-12 weeks after camp completion and plans for long-term follow-up assessments one, three and five years after inclusion.

Overall, we hypothesize that the multicomponent camp intervention will effectively reduce BE behavior in children and adolescents. Furthermore, we hypothesize that participants whose parents are randomized to receive the parental BED intervention will show a lower prevalence of BE behavior one year after the camp intervention compared with children whose parents receive standard care.

Eligibility criteria

Qualifiers

Attending the camp in Hobro or Fjordmark from January 2027 to December 2027

7-14 years of age at recruitment

Participants must have written informed consent from parent/guardian before camp to participate

At least one parent/guardian submit written informed consent to participate in the study with their child

Disqualifiers

A medical condition affecting dietary intake and/or eating behavior

Taking weight loss medication

The parent/guardian don't understand the written informed consent

Participant or parent/guardian are unwilling to or unable to comply with the study protocol and instructions given by the study staff.

Trial design

Treatments tested in this trial

  • A 10-week multicomponent camp intervention for children
  • A BED intervention for parents

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators